This site uses Google Analytics for tracking site performance.
Reasons for a negative Pharmaceutical Benefits Advisory Committee (PBAC) review in rare diseases in Australia: A comprehensive analysis
Andrew Mumford, Oliver Darlington, Sarah Jane Lyttle, Adelaide ShawThe experience and utilisation of patient reported outcomes (PROs) in Leber's hereditary optic neuropathy (LHON): A targeted literature review
Andrew Mumford, Joanne Mumford, Sarah Coyle, Jonathan Gibson, Harry LewisThe impact of differences in patient demographics on assessment of long-term cost-effectiveness in cohort level economic models
The impact of Leber's hereditary optic neuropathy (LHON) on quality of life: A systematic literature review
Andrew Mumford, Joanne Mumford, Harry Lewis, Jonathan Gibson, Sarah Coyle